The Future of Dementia Diagnosis
The diagnosis of neurodegenerative diseases, particularly dementia, often faces significant challenges. Many patients are diagnosed when symptoms are already evident, resulting in irreversible brain damage. However, what if we could glimpse the future of brain health years before cognitive decline becomes apparent? This groundbreaking potential is being explored by a Spanish research team that has developed a new biomarker for early dementia prediction.
The Study: Pioneering Early Detection
The future of medicine hinges on the ability to diagnose health conditions earlier, enhancing the effectiveness of treatments. A recent published article in Scientific Reports indicates a promising shift in dementia diagnostics. Researchers like Rubén Armañanzas from the DATAI Institute at the University of Navarra advocate for using electroencephalograms (EEGs) combined with artificial intelligence (AI) to predict dementia risk up to seven years before clinical diagnosis.
The Methodology: Breaking New Ground
To grasp the significance of this research, it is essential to examine the population studied: individuals with subjective cognitive impairment. These patients often report memory issues but present normal results in standard cognitive tests, leaving them without a clear diagnosis. Until now, this phase has posed a challenge in medicine, as there was no method to determine whether these memory complaints were early signs of Alzheimer’s disease or merely confusion.
This study, encompassing 88 older adults experiencing such cognitive issues, revealed that the brain sends out warning signals well before psychological tests can pick them up. The key lies in knowing how to interpret these signals.
A New Approach: EEG and AI Integration
The research employed a combination of methods to decode these early warning signs. Starting with an EEG, which is an inexpensive, quick, and non-invasive test to measure brain activity, researchers utilized the BrainScope technology platform to analyze EEG data. This platform identifies 14 specific features related to neuronal connectivity and brain wave patterns.
Once identified, an AI algorithm processes these patterns to assess whether the individual is at risk of developing mild cognitive impairment or dementia. Remarkably, the results show high precision in distinguishing patients who will progress towards these conditions from those who will not.
The Future: Clinical and Technological Advancements
The development of this biomarker is significant not only from a technological standpoint but also for its clinical implications. Current reliable tests for Alzheimer’s require painful lumbar punctures or expensive imaging techniques. In contrast, an EEG-based system integrated with AI could become a routine part of primary care protocols, offering a non-invasive and cost-effective approach to early diagnosis.
Detecting neurodegeneration at its earliest stages is crucial for allowing new treatments to act before significant damage occurs, ultimately improving quality of life for patients.
Images | Robina Weermeijer